Additive Antiatherogenic Effects of CETP rs708272 on Serum LDL Subfraction Levels in Patients with CHD Under Statin Therapy.
about
Additive Antiatherogenic Effects of CETP rs708272 on Serum LDL Subfraction Levels in Patients with CHD Under Statin Therapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Additive Antiatherogenic Effec ...... with CHD Under Statin Therapy.
@en
Additive Antiatherogenic Effec ...... with CHD Under Statin Therapy.
@nl
type
label
Additive Antiatherogenic Effec ...... with CHD Under Statin Therapy.
@en
Additive Antiatherogenic Effec ...... with CHD Under Statin Therapy.
@nl
prefLabel
Additive Antiatherogenic Effec ...... with CHD Under Statin Therapy.
@en
Additive Antiatherogenic Effec ...... with CHD Under Statin Therapy.
@nl
P2093
P2860
P1433
P1476
Additive Antiatherogenic Effec ...... with CHD Under Statin Therapy
@en
P2093
Allison P Eronat
Bengu Tokat
Deniz Kanca
Hulya Yilmaz-Aydogan
Oğuz Ozturk
Zehra Bugra
P2860
P2888
P304
P356
10.1007/S10528-016-9782-5
P50
P577
2016-11-30T00:00:00Z